Unbiased AI-powered news
Health and Human Services Secretary Robert F. Kennedy Jr. fired around 3,500 workers from the Food and Drug Administration last year. The agency is now seeking to hire more than 3,200 people, including scientific reviewers and investigators. As of late April, it had hired about 350.
fda.govHealth and Human Services Secretary Robert F. Kennedy Jr. fired around 3,500 workers from the Food and Drug Administration last year. The department is now aiming to hire more than 3,200 people, including scientific reviewers and investigators. As of late April the FDA had hired about 350 staff.
HHS leaders have acknowledged that earning the trust of and retaining staff is a priority. A spokesperson Andrew Nixon said the FDA is actively investing in its workforce to ensure continuity of expertise and prevent the loss of critical institutional knowledge.
The FDA commissioner has discussed the hiring plan in media appearances and town halls over the past few months.
Six current and former FDA staffers described the work they left after the reductions. The employees spoke about responsibilities they did not expect to depart. Their accounts detail operations at the agency one year after the cuts.
The reductions occurred after the Trump administration described the changes as a solution to bureaucratic bloat. HHS leaders have since recognized that a reduced workforce affects the department's ability to meet its objectives. The agency continues to recruit for scientific and investigative roles.
Single source — no framing comparison available.
nypost.comThe World Health Organization said Tuesday that 80 percent of new cases come from unknown transmission chains. As of Monday, 1,926 infections and 702 deaths have been recorded across three provinces.
New ScientistThe LiBBY trial of purified THC and CBD in a rapid-acting oil showed nearly 90 percent of 120 participants improved after 12 weeks. Results were presented at the Alzheimer’s Association International Conference but have not been peer reviewed.
comicbook.comDisney's live-action remake earned $43 million in the United States and Canada and $52 million internationally over its first three days. The $250 million film finished first at the domestic box office despite falling short of studio estimates.